MetaADEDB 2.0 @ LMMD
Fluconazole
(RFHAOTPXVQNOHP-UHFFFAOYSA-N)
Structure
SMILES
Fc1ccc(c(c1)F)C(Cn1cncn1)(Cn1cncn1)O
Type(s)
Approved; Investigational
ATC code(s)
D01AC15; J01RA07; J02AC01
Molecular Formula:
C13H12F2N6O
Molecular Weight:
306.271
Log P:
0.7358
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
1
TPSA:
81.65
CAS Number(s):
86386-73-4; 123631-92-5; 340962-81-4
Synonym(s)
1.
Fluconazole
2.
Apo-Fluconazole
3.
Béagyne
4.
Diflucan
5.
Fluc Hexal
6.
FlucoLich
7.
Flucobeta
8.
Fluconazol AL
9.
Fluconazol AbZ
10.
Fluconazol Stada
11.
Fluconazol von ct
12.
Fluconazol-Isis
13.
Fluconazol-ratiopharm
14.
Flunazul
15.
Fungata
16.
Lavisa
17.
Loitin
18.
Neofomiral
19.
Oxifungol
20.
Solacap
21.
Triflucan
22.
UK-49858
23.
Zonal
24.
Apo Fluconazole
25.
Fluconazol Isis
26.
Fluconazol ratiopharm
27.
UK 49858
28.
UK49858
External Link(s)
MeSHD015725
PubChem Compound3365
BindingDB25817
ChEBI46081
CHEMBLCHEMBL106
DrugBankDB00196
DrugCentral1187
KEGGcpd:C07002
dr:D00322
Therapeutic Target DatabaseD09LNI
ZINC4009
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 220
Canada Vigilance: 30
Canada Vigilance
US FAERS
2PruritusFAERS: 96
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
3NauseaFAERS: 89
Canada Vigilance: 6
9762826CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
4UrticariaFAERS: 78
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
5HeadacheFAERS: 71
Canada Vigilance: 9
9309372
9762826
CTD
SIDER
Canada Vigilance
US FAERS
6ErythemaFAERS: 69
Canada Vigilance: 8
Canada Vigilance
OFFSIDES
US FAERS
7DizzinessFAERS: 51
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
8HypersensitivityFAERS: 47
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
9PainFAERS: 47
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
10VomitingFAERS: 44
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
11Lip swellingFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
12MalaiseFAERS: 41
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
13AlopeciaFAERS: 40
Canada Vigilance: 1
9309372CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
14Burning sensationFAERS: 40
Canada Vigilance: 1
Canada Vigilance
US FAERS
15FatigueFAERS: 38
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
16Drug exposure during pregnancyFAERS: 33US FAERS
17Maternal exposure during pregnancyFAERS: 32
Canada Vigilance: 3
Canada Vigilance
US FAERS
18Stevens-Johnson SyndromeFAERS: 32
Canada Vigilance: 5
25811541CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
19Feeling abnormalFAERS: 31SIDER
US FAERS
20SwellingFAERS: 30US FAERS
21Abdominal PainFAERS: 27
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
22Intestinal PerforationFAERS: 24US FAERS
23Drug resistanceFAERS: 23US FAERS
24Medication ErrorFAERS: 23US FAERS
25PalpitationsFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
26Abdominal discomfortFAERS: 21OFFSIDES
US FAERS
27Vulvovaginal pruritusFAERS: 21US FAERS
28AstheniaFAERS: 20
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
29Rash erythematousFAERS: 19
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
30EczemaFAERS: 18US FAERS
31MyalgiaFAERS: 18
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
32Pathogen resistanceFAERS: 18SIDER
US FAERS
33Pharmaceutical product complaintFAERS: 18US FAERS
34treatment failureFAERS: 18
Canada Vigilance: 3
Canada Vigilance
US FAERS
35PancytopeniaFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
36ThrombocytopeniaFAERS: 16
Canada Vigilance: 1
24459006CTD
SIDER
Canada Vigilance
US FAERS
37TachycardiaFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
38TinnitusFAERS: 15US FAERS
39ChillsFAERS: 14
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
40Product substitution issueFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
41Erythema MultiformeFAERS: 13SIDER
US FAERS
42Skin irritationFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
43ArthralgiaFAERS: 12
Canada Vigilance: 6
Canada Vigilance
US FAERS
44Chest PainFAERS: 12OFFSIDES
US FAERS
45Drug dispensing errorFAERS: 12US FAERS
46InfectionFAERS: 12
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
47Kounis SyndromeFAERS: 12
Canada Vigilance: 10
Canada Vigilance
US FAERS
48Toxic Epidermal NecrolysisFAERS: 12
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
49VertigoFAERS: 12
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
50Vulvovaginal discomfortFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
51jaundiceFAERS: 12
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
52Drug ineffective for unapproved indicationFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
53Fixed eruptionFAERS: 11
Canada Vigilance: 3
Canada Vigilance
US FAERS
54HypotensionFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
55Product quality issueFAERS: 11US FAERS
56Therapeutic response unexpectedFAERS: 11US FAERS
57AnuriaFAERS: 10OFFSIDES
US FAERS
58AnxietyFAERS: 10OFFSIDES
US FAERS
59Back PainFAERS: 10SIDER
US FAERS
60CandidiasisFAERS: 10

View details

CTD
US FAERS
61Chest discomfortFAERS: 10US FAERS
62ConstipationFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
63DiscomfortFAERS: 10SIDER
US FAERS
64DyspepsiaFAERS: 10OFFSIDES
SIDER
US FAERS
65No adverse eventFAERS: 10US FAERS
66Product use issueFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
67Septic ShockFAERS: 10OFFSIDES
US FAERS
68Drug effect incompleteFAERS: 9US FAERS
69MydriasisFAERS: 9US FAERS
70Oropharyngeal painFAERS: 9
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
71Product use in unapproved indicationFAERS: 9US FAERS
72ScotomaFAERS: 9SIDER
US FAERS
73Skin lesionFAERS: 9OFFSIDES
US FAERS
74Vulvovaginal burning sensationFAERS: 9US FAERS
75Weight decreasedFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
76XanthopsiaFAERS: 9US FAERS
77AgeusiaFAERS: 8US FAERS
78Alanine Aminotransferase IncreasedFAERS: 8
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
79AngioedemaFAERS: 81679171CTD
SIDER
US FAERS
80DehydrationFAERS: 8OFFSIDES
US FAERS
81FlushingFAERS: 8SIDER
US FAERS
82Oral candidiasisFAERS: 8US FAERS
83OverdoseFAERS: 8US FAERS
84PneumoniaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
85SepsisFAERS: 8
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
86SomnolenceFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
87Tongue blisteringFAERS: 8US FAERS
88TremorFAERS: 8
Canada Vigilance: 6
1291872
2101860
CTD
SIDER
Canada Vigilance
US FAERS
89Wrong technique in product usage processFAERS: 8US FAERS
90AspergillosisFAERS: 718486603
20943191
CTD
SIDER
US FAERS
91BradycardiaFAERS: 7US FAERS
92Cardiac ArrestFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
93DysgeusiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
94FlatulenceFAERS: 7SIDER
US FAERS
95Incorrect dose administeredFAERS: 7US FAERS
96InfluenzaFAERS: 7US FAERS
97Intentional product misuseFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
98Oral painFAERS: 7US FAERS
99Pain of skinFAERS: 7US FAERS
100Product solubility abnormalFAERS: 7US FAERS
101Throat irritationFAERS: 7US FAERS
102Vaginal mucosal blisteringFAERS: 7US FAERS
103Visual ImpairmentFAERS: 7
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
104Vulvovaginal painFAERS: 7US FAERS
105Aspartate Aminotransferase IncreasedFAERS: 6
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
106Blood corticosterone increasedFAERS: 6US FAERS
107Bone painFAERS: 6OFFSIDES
US FAERS
108CheilitisFAERS: 6US FAERS
109DeafnessFAERS: 6
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
110DeliriumFAERS: 612850665
18585543
CTD
US FAERS
111Disease ProgressionFAERS: 6US FAERS
112Disease recurrenceFAERS: 6OFFSIDES
US FAERS
113Drug exposure via breast milkFAERS: 6US FAERS
114Fixed drug eruptionFAERS: 6US FAERS
115InflammationFAERS: 6US FAERS
116Long QT SyndromeFAERS: 6

View details

CTD
US FAERS
117StomatitisFAERS: 6SIDER
US FAERS
118SyncopeFAERS: 611144697CTD
US FAERS
119Transaminases increasedFAERS: 6US FAERS
120Troponin increasedFAERS: 6US FAERS
121White blood cell count decreasedFAERS: 6US FAERS
122AbasiaFAERS: 5OFFSIDES
US FAERS
123Altered state of consciousnessFAERS: 5US FAERS
124Angina PectorisFAERS: 5US FAERS
125EosinophiliaFAERS: 59309372CTD
US FAERS
126General physical health deteriorationFAERS: 5OFFSIDES
US FAERS
127Hypoplastic Left Heart SyndromeFAERS: 5US FAERS
128Inappropriate schedule of drug administrationFAERS: 5US FAERS
129LethargyFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
130NervousnessFAERS: 5SIDER
US FAERS
131NeutropeniaFAERS: 5SIDER
US FAERS
132Peripheral swellingFAERS: 5
Canada Vigilance: 3
Canada Vigilance
US FAERS
133Toxicity to various agentsFAERS: 5US FAERS
134Urinary tract infectionFAERS: 5US FAERS
135Anaphylactic shockFAERS: 4SIDER
US FAERS
136Anterior displaced anusFAERS: 4US FAERS
137AsthmaFAERS: 4US FAERS
138BlindnessFAERS: 4US FAERS
139Blood blisterFAERS: 4US FAERS
140Blood glucose decreasedFAERS: 4OFFSIDES
US FAERS
141Blood potassium decreasedFAERS: 4OFFSIDES
US FAERS
142CraniosynostosisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
143DisabilityFAERS: 4US FAERS
144Dry skinFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
145EpistaxisFAERS: 4OFFSIDES
US FAERS
146Eye irritationFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
147Eye painFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
148Gastrointestinal PainFAERS: 4SIDER
US FAERS
149MiliariaFAERS: 4US FAERS
150Neonatal disorderFAERS: 4US FAERS
151Oropharyngeal blisteringFAERS: 4US FAERS
152PetechiaeFAERS: 4US FAERS
153PhotophobiaFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
154PregnancyFAERS: 4SIDER
US FAERS
155Product taste abnormalFAERS: 4US FAERS
156Reaction to excipientFAERS: 4US FAERS
157RetchingFAERS: 4US FAERS
158Retinal toxicityFAERS: 4US FAERS
159Retroperitoneal fibrosisFAERS: 4US FAERS
160ScabFAERS: 4US FAERS
161Therapeutic response unexpected with drug substitutionFAERS: 4US FAERS
162Ventricular FibrillationFAERS: 4OFFSIDES
US FAERS
163Activities of daily living impairedFAERS: 3US FAERS
164AgitationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
165AmnesiaFAERS: 3US FAERS
166Anorectal discomfortFAERS: 3US FAERS
167Burning Mouth SyndromeFAERS: 3US FAERS
168Cerebrovascular accidentFAERS: 3US FAERS
169CholestasisFAERS: 3SIDER
US FAERS
170Cholestatic liver injuryFAERS: 3US FAERS
171ChromaturiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
172Clostridium colitisFAERS: 3US FAERS
173CryingFAERS: 3US FAERS
174Depressed Level of ConsciousnessFAERS: 3US FAERS
175DermatitisFAERS: 3SIDER
US FAERS
176Diabetes MellitusFAERS: 3US FAERS
177Diffuse alopeciaFAERS: 3US FAERS
178Drug administration errorFAERS: 3US FAERS
179Drug toxicityFAERS: 3OFFSIDES
US FAERS
180DysphoniaFAERS: 3US FAERS
181DysuriaFAERS: 3OFFSIDES
US FAERS
182Ear congestionFAERS: 3OFFSIDES
US FAERS
183Exposure during breast feedingFAERS: 3US FAERS
184Eyelids pruritusFAERS: 3US FAERS
185Gene MutationFAERS: 3US FAERS
186HepatotoxicityFAERS: 3US FAERS
187HypophagiaFAERS: 3US FAERS
188Impaired work abilityFAERS: 3US FAERS
189Infectious disease carrierFAERS: 3US FAERS
190Mental impairmentFAERS: 3US FAERS
191Mouth swellingFAERS: 3US FAERS
192Oral fungal infectionFAERS: 3US FAERS
193Oral pruritusFAERS: 3US FAERS
194Pharyngolaryngeal PainFAERS: 3US FAERS
195Prescription drug used without a prescriptionFAERS: 3US FAERS
196Procedural complicationFAERS: 3US FAERS
197Respiratory distressFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
198RestlessnessFAERS: 3US FAERS
199SinusitisFAERS: 3OFFSIDES
US FAERS
200Skin reactionFAERS: 3US FAERS
201SneezingFAERS: 3US FAERS
202StillbirthFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
203Therapeutic response changedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
204Thrombocytopenic purpuraFAERS: 3US FAERS
205Troponin I increasedFAERS: 3US FAERS
206Urinary RetentionFAERS: 3US FAERS
207Vaginal DischargeFAERS: 3SIDER
US FAERS
208Vanishing bile duct syndromeFAERS: 3US FAERS
209Ventricular arrhythmiaFAERS: 3US FAERS
210WheezingFAERS: 3US FAERS
211AcneFAERS: 2SIDER
US FAERS
212Acute sinusitisFAERS: 2US FAERS
213Anaphylactoid ReactionFAERS: 2US FAERS
214Aphthous StomatitisFAERS: 2US FAERS
215Arterial thrombosisFAERS: 2US FAERS
216ArthritisFAERS: 2OFFSIDES
US FAERS
217BedriddenFAERS: 2US FAERS
218Blood alkaline phosphatase increasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
219Blood amylase increasedFAERS: 2OFFSIDES
US FAERS
220Blood creatinine increasedFAERS: 2OFFSIDES
US FAERS
221Blood glucose fluctuationFAERS: 2OFFSIDES
US FAERS
222Blood urea increasedFAERS: 2OFFSIDES
US FAERS
223BrachycephalyFAERS: 2US FAERS
224BronchiolitisFAERS: 2US FAERS
225Cardiac valve vegetationFAERS: 2US FAERS
226Cerebral disorderFAERS: 2US FAERS
227CholangitisFAERS: 2US FAERS
228ChoreaFAERS: 2US FAERS
229ChoroiditisFAERS: 2US FAERS
230Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
231Cleft PalateFAERS: 2
Canada Vigilance: 2
16781842CTD
Canada Vigilance
US FAERS
232Completed SuicideFAERS: 2US FAERS
233Deep Vein ThrombosisFAERS: 2US FAERS
234DisorientationFAERS: 2US FAERS
235DysmorphismFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
236Electrolyte imbalanceFAERS: 2US FAERS
237Electromechanical dissociationFAERS: 2US FAERS
238Emotional disorderFAERS: 2US FAERS
239Excessive eye blinkingFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
240Expired drug administeredFAERS: 2US FAERS
241Exposure via breast milkFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
242Extra dose administeredFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
243ExtravasationFAERS: 2US FAERS
244Feeling of body temperature changeFAERS: 2OFFSIDES
US FAERS
245Food cravingFAERS: 2US FAERS
246Gamma-Glutamyltransferase IncreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
247Gastrointestinal perforationFAERS: 2US FAERS
248Genital HerpesFAERS: 2US FAERS
249Genital swellingFAERS: 2US FAERS
250HepatitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
251Hormone level abnormalFAERS: 2US FAERS
252HydrocephalusFAERS: 2US FAERS
253HyperpyrexiaFAERS: 2US FAERS
254HyperreflexiaFAERS: 2US FAERS
255HyperventilationFAERS: 2US FAERS
256HypospadiasFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
257HypoxiaFAERS: 2OFFSIDES
SIDER
US FAERS
258Impaired driving abilityFAERS: 2US FAERS
259Inappropriate schedule of product administrationFAERS: 2US FAERS
260LeukopeniaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
261MaculeFAERS: 2US FAERS
262Mental status changesFAERS: 2OFFSIDES
US FAERS
263Multi-organ disorderFAERS: 2US FAERS
264Musculoskeletal stiffnessFAERS: 2US FAERS
265Nail pigmentationFAERS: 2US FAERS
266NasopharyngitisFAERS: 2OFFSIDES
US FAERS
267Neck PainFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
268Neonatal pneumoniaFAERS: 2US FAERS
269NephrolithiasisFAERS: 2OFFSIDES
US FAERS
270Neutrophil count decreasedFAERS: 2US FAERS
271Ocular icterusFAERS: 2US FAERS
272OliguriaFAERS: 2OFFSIDES
US FAERS
273PancreatitisFAERS: 2OFFSIDES
US FAERS
274Penile blisterFAERS: 2US FAERS
275PoisoningFAERS: 2US FAERS
276PolyarthritisFAERS: 2US FAERS
277Poor quality drug administeredFAERS: 2US FAERS
278Product measured potency issueFAERS: 2US FAERS
279Product physical issueFAERS: 2US FAERS
280Product use complaintFAERS: 2US FAERS
281Productive CoughFAERS: 2OFFSIDES
US FAERS
282Rebound effectFAERS: 2US FAERS
283RegurgitationFAERS: 2US FAERS
284Retinal Vein OcclusionFAERS: 2US FAERS
285RhabdomyolysisFAERS: 2US FAERS
286RhinitisFAERS: 2US FAERS
287Similar reaction on previous exposure to drugFAERS: 2US FAERS
288Skin UlcerFAERS: 2US FAERS
289Skin tightnessFAERS: 2OFFSIDES
US FAERS
290SynostosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
291TorticollisFAERS: 2US FAERS
292TracheomalaciaFAERS: 2US FAERS
293TrichophytosisFAERS: 2US FAERS
294Trichosporon infectionFAERS: 2US FAERS
295Unevaluable eventFAERS: 2US FAERS
296UveitisFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
297Vanishing twin syndromeFAERS: 2US FAERS
298Vascular purpuraFAERS: 2SIDER
US FAERS
299Visual disturbanceFAERS: 2US FAERS
300Vitamin D DeficiencyFAERS: 2US FAERS
301kyphosisFAERS: 2US FAERS
302nervous system disorderFAERS: 2SIDER
US FAERS
303pseudomembranous colitisFAERS: 2US FAERS
304Abdominal adhesionsFAERS: 1US FAERS
305Abortion completeFAERS: 1US FAERS
306AbscessFAERS: 1OFFSIDES
US FAERS
307Accidental exposure to productFAERS: 1US FAERS
308Accidental overdoseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
309Acoustic NeuromaFAERS: 1US FAERS
310Acute graft versus host disease in intestineFAERS: 1US FAERS
311Acute kidney injuryFAERS: 1
Canada Vigilance: 1
18363177CTD
Canada Vigilance
US FAERS
312Acute myocardial infarctionFAERS: 1US FAERS
313AgranulocytosisFAERS: 124459006CTD
SIDER
US FAERS
314Alcohol IntoleranceFAERS: 1US FAERS
315Allergy test positiveFAERS: 1US FAERS
316AnencephalyFAERS: 1US FAERS
317AnorexiaFAERS: 19309372CTD
OFFSIDES
SIDER
US FAERS
318AnosmiaFAERS: 1OFFSIDES
US FAERS
319Anticholinergic SyndromeFAERS: 1US FAERS
320Antidepressant drug level above therapeuticFAERS: 1US FAERS
321Antimicrobial susceptibility test resistantFAERS: 1US FAERS
322AphoniaFAERS: 1US FAERS
323ApoptosisFAERS: 1US FAERS
324Apparent deathFAERS: 1US FAERS
325Apparent life threatening eventFAERS: 1US FAERS
326ArachnodactylyFAERS: 1US FAERS
327ArthropathyFAERS: 1US FAERS
328AscitesFAERS: 1OFFSIDES
US FAERS
329AtelectasisFAERS: 1OFFSIDES
US FAERS
330Atrial FibrillationFAERS: 1US FAERS
331Atrioventricular BlockFAERS: 1US FAERS
332BabesiosisFAERS: 1US FAERS
333Bacterial test positiveFAERS: 1OFFSIDES
US FAERS
334Benign Prostatic HyperplasiaFAERS: 1US FAERS
335Bilateral hydronephrosisFAERS: 1US FAERS
336Blood cholesterol increasedFAERS: 1US FAERS
337Blood corticosterone abnormalFAERS: 1US FAERS
338Blood electrolytes abnormalFAERS: 1US FAERS
339Blood glucose abnormalFAERS: 1US FAERS
340Blood glucose increasedFAERS: 1US FAERS
341Blood insulin decreasedFAERS: 1US FAERS
342Blood magnesium decreasedFAERS: 1OFFSIDES
US FAERS
343Blood potassium increasedFAERS: 1OFFSIDES
US FAERS
344Blood sodium decreasedFAERS: 1US FAERS
345Blood sodium increasedFAERS: 1OFFSIDES
US FAERS
346Blood testosterone decreasedFAERS: 1US FAERS
347Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
348Blood triglycerides increasedFAERS: 1OFFSIDES
SIDER
US FAERS
349BronchitisFAERS: 1OFFSIDES
US FAERS
350Bronchoalveolar lavage abnormalFAERS: 1US FAERS
351Bronchopulmonary AspergillosisFAERS: 1US FAERS
352Buccal mucosal rougheningFAERS: 1US FAERS
353Butterfly rashFAERS: 1US FAERS
354Cardiac discomfortFAERS: 1US FAERS
355Catheter related complicationFAERS: 1OFFSIDES
US FAERS
356Catheter site infectionFAERS: 1US FAERS
357Central Nervous System InfectionFAERS: 1US FAERS
358Cerebellar HypoplasiaFAERS: 1US FAERS
359Cerebral InfarctionFAERS: 1US FAERS
360Cerebral PalsyFAERS: 1US FAERS
361Choking sensationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
362CholelithiasisFAERS: 1US FAERS
363Chorioretinal scarFAERS: 1US FAERS
364ClonusFAERS: 1US FAERS
365Clostridium difficile infectionFAERS: 1US FAERS
366CoccidioidomycosisFAERS: 1OFFSIDES
US FAERS
367Complications of maternal exposure to therapeutic drugsFAERS: 1US FAERS
368Congenital anomaly in offspringFAERS: 1US FAERS
369Congenital epiglottal anomalyFAERS: 1US FAERS
370Congenital neurological disorderFAERS: 1US FAERS
371Congenital renal disorderFAERS: 1US FAERS
372Creatinine renal clearance decreasedFAERS: 1US FAERS
373Culture positiveFAERS: 1OFFSIDES
US FAERS
374CyanosisFAERS: 1SIDER
US FAERS
375CystitisFAERS: 1US FAERS
376Cytolytic hepatitisFAERS: 1OFFSIDES
US FAERS
377CytopeniaFAERS: 1US FAERS
378Deafness NeurosensoryFAERS: 1US FAERS
379DementiaFAERS: 1US FAERS
380Diabetes InsipidusFAERS: 1US FAERS
381DiplopiaFAERS: 1US FAERS
382Disseminated Intravascular CoagulationFAERS: 1US FAERS
383Dose calculation errorFAERS: 1US FAERS
384Double Outlet Right VentricleFAERS: 1US FAERS
385Drug dose omissionFAERS: 1US FAERS
386Drug exposure before pregnancyFAERS: 1US FAERS
387Drug level increasedFAERS: 1US FAERS
388Drug prescribing errorFAERS: 1US FAERS
389Drug screen false positiveFAERS: 1US FAERS
390Drug screen positiveFAERS: 1US FAERS
391DyscheziaFAERS: 1US FAERS
392DystoniaFAERS: 1US FAERS
393Economic problemFAERS: 1OFFSIDES
US FAERS
394Electrocardiogram R on T phenomenonFAERS: 1US FAERS
395Electrocardiogram abnormalFAERS: 1US FAERS
396Emotional distressFAERS: 1OFFSIDES
US FAERS
397EnophthalmosFAERS: 1US FAERS
398Enzyme InhibitionFAERS: 1US FAERS
399Epidermal necrosisFAERS: 1OFFSIDES
US FAERS
400Epigastric discomfortFAERS: 1US FAERS
401EpilepsyFAERS: 1US FAERS
402Erosive balanitisFAERS: 1US FAERS
403EructationFAERS: 1US FAERS
404Erythema NodosumFAERS: 1US FAERS
405ExophthalmosFAERS: 1US FAERS
406Expired product administeredFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
407Exudative retinopathyFAERS: 1US FAERS
408Eye BurnsFAERS: 1US FAERS
409Eye RednessFAERS: 1US FAERS
410Eye allergyFAERS: 1US FAERS
411Eyelid irritationFAERS: 1US FAERS
412Facial PainFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
413False positive laboratory resultFAERS: 1US FAERS
414Febrile NeutropeniaFAERS: 1OFFSIDES
US FAERS
415Feeling ColdFAERS: 1US FAERS
416Feeling jitteryFAERS: 1US FAERS
417FibromyalgiaFAERS: 1OFFSIDES
US FAERS
418Finger hypoplasiaFAERS: 1US FAERS
419Flat affectFAERS: 1US FAERS
420Focal Nodular HyperplasiaFAERS: 1US FAERS
421FolliculitisFAERS: 1US FAERS
422Food AllergyFAERS: 1US FAERS
423Foreign body sensation in eyesFAERS: 1US FAERS
424FractureFAERS: 1US FAERS
425Gastrointestinal candidiasisFAERS: 1US FAERS
426Gastrointestinal inflammationFAERS: 1US FAERS
427Genital burning sensationFAERS: 1US FAERS
428Genital erythemaFAERS: 1US FAERS
429Gingival blisterFAERS: 1US FAERS
430GlaucomaFAERS: 1OFFSIDES
US FAERS
431GlossitisFAERS: 1US FAERS
432GranulomaFAERS: 1US FAERS
433HELLP SyndromeFAERS: 1US FAERS
434Hepatic EncephalopathyFAERS: 1US FAERS
435Hepatic InfectionFAERS: 1US FAERS
436Hepatitis C antibody positiveFAERS: 1US FAERS
437HepatomegalyFAERS: 123721867
25656644
CTD
US FAERS
438Herpes dermatitisFAERS: 1US FAERS
439HydropneumothoraxFAERS: 1US FAERS
440HyperchlorhydriaFAERS: 1US FAERS
441HypersomniaFAERS: 1US FAERS
442Hypoaesthesia facialFAERS: 1US FAERS
443IleusFAERS: 1SIDER
US FAERS
444Immune thrombocytopenic purpuraFAERS: 1US FAERS
445ImmunosuppressionFAERS: 1OFFSIDES
US FAERS
446IncoherentFAERS: 1US FAERS
447Incorrect product storageFAERS: 1US FAERS
448Incorrect route of drug administrationFAERS: 1US FAERS
449Incorrect route of product administrationFAERS: 1US FAERS
450Increased tendency to bruiseFAERS: 1US FAERS
451Infusion Site ExtravasationFAERS: 1US FAERS
452Infusion site reactionFAERS: 1US FAERS
453Injection Site ReactionFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
454Injection site extravasationFAERS: 1US FAERS
455Injection site inflammationFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
456Intercepted medication errorFAERS: 1US FAERS
457Intestinal ObstructionFAERS: 1US FAERS
458Irritable Bowel SyndromeFAERS: 1US FAERS
459Joint Range of Motion DecreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
460Joint stiffnessFAERS: 1OFFSIDES
US FAERS
461Joint swellingFAERS: 1US FAERS
462Joint warmthFAERS: 1US FAERS
463Lichen PlanusFAERS: 1US FAERS
464Lip erythemaFAERS: 1US FAERS
465Lip exfoliationFAERS: 1US FAERS
466Lip pruritusFAERS: 1US FAERS
467Lipase increasedFAERS: 1US FAERS
468Livedo ReticularisFAERS: 1OFFSIDES
US FAERS
469Liver transplant rejectionFAERS: 1US FAERS
470Low Cardiac Output SyndromeFAERS: 1US FAERS
471Lower respiratory tract infectionFAERS: 1US FAERS
472Lupus-like syndromeFAERS: 1US FAERS
473Lyme DiseaseFAERS: 1US FAERS
474LymphohistiocytosisFAERS: 1US FAERS
475LymphomaFAERS: 1US FAERS
476Malignant neoplasm progressionFAERS: 1OFFSIDES
US FAERS
477Medical device complicationFAERS: 1US FAERS
478Medication residue presentFAERS: 1US FAERS
479Memory impairmentFAERS: 1US FAERS
480MeningitisFAERS: 1US FAERS
481MenorrhagiaFAERS: 1SIDER
US FAERS
482Mesenteric vascular insufficiencyFAERS: 1US FAERS
483Middle insomniaFAERS: 1US FAERS
484Mood swingsFAERS: 1US FAERS
485MucormycosisFAERS: 1US FAERS
486Muscle SpasticityFAERS: 1US FAERS
487Muscle tightnessFAERS: 1OFFSIDES
US FAERS
488Musculoskeletal chest painFAERS: 1OFFSIDES
US FAERS
489Myocardial InfarctionFAERS: 1US FAERS
490MyoglobinuriaFAERS: 1US FAERS
491MyopathyFAERS: 1US FAERS
492Nasal discomfortFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
493Nephrotic SyndromeFAERS: 1US FAERS
494NeuralgiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
495NeuritisFAERS: 1US FAERS
496NeuropathyFAERS: 1US FAERS
497Night sweatsFAERS: 1US FAERS
498No reaction on previous exposure to drugFAERS: 1US FAERS
499Oral mucosal erythemaFAERS: 1US FAERS
500Oropharyngeal discomfortFAERS: 1US FAERS
501OsteoporosisFAERS: 1OFFSIDES
US FAERS
502PCO2 increasedFAERS: 1US FAERS
503PO2 decreasedFAERS: 1US FAERS
504PallorFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
505Palmar erythemaFAERS: 1US FAERS
506Pancreatic NeoplasmFAERS: 1US FAERS
507Panic DisorderFAERS: 1US FAERS
508PapuleFAERS: 1US FAERS
509ParanoiaFAERS: 1OFFSIDES
US FAERS
510ParaparesisFAERS: 1US FAERS
511ParaplegiaFAERS: 1US FAERS
512ParesisFAERS: 1US FAERS
513Penile swellingFAERS: 1US FAERS
514PericarditisFAERS: 1OFFSIDES
US FAERS
515Peritoneal DialysisFAERS: 1US FAERS
516Peritoneal fluid analysis abnormalFAERS: 1US FAERS
517Pharyngeal swellingFAERS: 1US FAERS
518Pilonidal cyst congenitalFAERS: 1US FAERS
519Pleuritic painFAERS: 1US FAERS
520PolyneuropathyFAERS: 1US FAERS
521Post procedural infectionFAERS: 1US FAERS
522Post procedural inflammationFAERS: 1US FAERS
523Postural Orthostatic Tachycardia SyndromeFAERS: 1US FAERS
524Potentiating drug interactionFAERS: 1US FAERS
525Pre-existing condition improvedFAERS: 1US FAERS
526PresyncopeFAERS: 1US FAERS
527Product contaminationFAERS: 1US FAERS
528Product formulation issueFAERS: 1US FAERS
529Product friableFAERS: 1US FAERS
530Product label issueFAERS: 1US FAERS
531Product packaging issueFAERS: 1US FAERS
532Product packaging quantity issueFAERS: 1US FAERS
533Product physical consistency issueFAERS: 1US FAERS
534Prostatic ObstructionFAERS: 1US FAERS
535Puerperal pyrexiaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
536Pulmonary EmbolismFAERS: 1US FAERS
537Pulmonary Valve StenosisFAERS: 1OFFSIDES
US FAERS
538Pulmonary malformationFAERS: 1US FAERS
539Pulmonary vascular disorderFAERS: 1US FAERS
540Pulse waveformFAERS: 1US FAERS
541Pulse waveform abnormalFAERS: 1US FAERS
542PurpuraFAERS: 1SIDER
US FAERS
543PyelonephritisFAERS: 1US FAERS
544QuadriparesisFAERS: 1US FAERS
545Quality of life decreasedFAERS: 1OFFSIDES
US FAERS
546Reaction to drug excipientsFAERS: 1US FAERS
547Renal hydroceleFAERS: 1US FAERS
548Renal tubular disorderFAERS: 1US FAERS
549Renal tubular necrosisFAERS: 1OFFSIDES
US FAERS
550Respiratory FailureFAERS: 1OFFSIDES
US FAERS
551Respiratory tract congestionFAERS: 1US FAERS
552Respiratory tract irritationFAERS: 1US FAERS
553ReticulocytopeniaFAERS: 1US FAERS
554Retinal Vascular DisorderFAERS: 1US FAERS
555SciaticaFAERS: 1US FAERS
556SclerodermaFAERS: 1US FAERS
557Secretion dischargeFAERS: 1US FAERS
558Sinoatrial BlockFAERS: 1US FAERS
559Sinus TachycardiaFAERS: 1US FAERS
560Sinus headacheFAERS: 1US FAERS
561Skeletal injuryFAERS: 1US FAERS
562Skin ErosionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
563Skin hypertrophyFAERS: 1OFFSIDES
US FAERS
564Sleep TalkingFAERS: 1US FAERS
565Sleep disorder due to general medical condition, insomnia typeFAERS: 1US FAERS
566Squamous cell carcinomaFAERS: 1US FAERS
567Stasis dermatitisFAERS: 1US FAERS
568Status EpilepticusFAERS: 1US FAERS
569StressFAERS: 1US FAERS
570Supraventricular tachycardiaFAERS: 1US FAERS
571Suspected counterfeit productFAERS: 1US FAERS
572Symmetrical drug-related intertriginous and flexural exanthemaFAERS: 1US FAERS
573SyndactylyFAERS: 1US FAERS
574Therapeutic product effect incompleteFAERS: 1US FAERS
575Therapeutic product ineffectiveFAERS: 1US FAERS
576Therapy non-responderFAERS: 1US FAERS
577Thermal burnFAERS: 1US FAERS
578ThirstFAERS: 1SIDER
US FAERS
579ThrombosisFAERS: 1US FAERS
580Tongue eruptionFAERS: 1US FAERS
581Tongue exfoliationFAERS: 1US FAERS
582Transaminases abnormalFAERS: 1US FAERS
583Trisomy 21FAERS: 1US FAERS
584TuberculosisFAERS: 1US FAERS
585Ultrasound abdomen abnormalFAERS: 1US FAERS
586UnderweightFAERS: 1US FAERS
587Unresponsive to stimuliFAERS: 1US FAERS
588Urinary tract infection fungalFAERS: 1OFFSIDES
US FAERS
589Urine amphetamine positiveFAERS: 1US FAERS
590VIIth nerve paralysisFAERS: 1US FAERS
591Vaginal lesionFAERS: 1US FAERS
592Vaginal painFAERS: 1US FAERS
593VaginitisFAERS: 1US FAERS
594VasculitisFAERS: 1US FAERS
595Vital functions abnormalFAERS: 1US FAERS
596Vitreous floatersFAERS: 1US FAERS
597VitritisFAERS: 1US FAERS
598Vulvovaginal mycotic infectionFAERS: 1US FAERS
599Vulvovaginal swellingFAERS: 1US FAERS
600Wheelchair userFAERS: 1OFFSIDES
US FAERS
601Wrong drug administeredFAERS: 1OFFSIDES
US FAERS
602furuncleFAERS: 1OFFSIDES
US FAERS
603Abdominal InfectionOFFSIDES
604Abdominal wound dehiscenceOFFSIDES
605Abnormal visionOFFSIDES
SIDER
606Abnormalities, Drug-Induced8838193CTD
607AcanthomaOFFSIDES
608Acid refluxOFFSIDES
609AcidosisOFFSIDES
610Acute Coronary SyndromeOFFSIDES
611Acute bronchitisOFFSIDES
612Acute otitis mediaOFFSIDES
613Acute respiratory failureOFFSIDES
614AdenocarcinomaOFFSIDES
615AdenomaOFFSIDES
616Alcohol abuseSIDER
617Allogenic bone marrow transplantation therapyOFFSIDES
618AlveolitisOFFSIDES
619AmenorrheaOFFSIDES
620Ammonia increasedOFFSIDES
621Anal erosionOFFSIDES
622Angular cheilitisCanada Vigilance: 1Canada Vigilance
623AnhedoniaOFFSIDES
624Anticonvulsant drug level increasedOFFSIDES
625Antley-Bixler Syndrome Phenotype14758361CTD
626Arteriovenous fistula site complicationOFFSIDES
627Arthropod biteOFFSIDES
628AsterixisOFFSIDES
629AstrocytomaOFFSIDES
630AtaxiaSIDER
631AthetosisOFFSIDES
632Atrial FlutterOFFSIDES
633Atrial tachycardiaOFFSIDES
634Atrioventricular Septal DefectCanada Vigilance: 1Canada Vigilance
635Autoimmune hepatitisOFFSIDES
636Bacteria stool identifiedOFFSIDES
637Bacteria urine no organism observedOFFSIDES
638Basal cell carcinomaOFFSIDES
639Benign neoplasm of thyroid glandOFFSIDES
640Blastomycosis7792710CTD
641Blood GlucoseOFFSIDES
642Blood and lymphatic system disordersSIDER
643Blood beta-D-glucan increasedOFFSIDES
644Blood bilirubin abnormalOFFSIDES
645Blood bilirubin unconjugated increasedOFFSIDES
646Blood chloride decreasedOFFSIDES
647Blood cholesterol abnormalOFFSIDES
648Blood cholesterolOFFSIDES
649Blood copper increasedOFFSIDES
650Blood cortisol abnormalOFFSIDES
651Blood immunoglobulin G increasedOFFSIDES
652Blood lactate dehydrogenase increasedCanada Vigilance: 1Canada Vigilance
OFFSIDES
653Blood magnesium increasedOFFSIDES
654Blood pH decreasedOFFSIDES
655Blood potassiumOFFSIDES
656Blood sodiumOFFSIDES
657Blood thyroid stimulating hormoneOFFSIDES
658Blood uric acidOFFSIDES
659Blood urine presentOFFSIDES
660Bone lesionOFFSIDES
661Brain DeathOFFSIDES
662Breast cancer recurrentOFFSIDES
663Bronchoalveolar LavageOFFSIDES
664BronchopneumoniaOFFSIDES
665Bronchopulmonary DysplasiaCanada Vigilance: 1Canada Vigilance
666Candidiasis, Vulvovaginal18498300
23546773
CTD
667CandiduriaOFFSIDES
668Cardiac FlutterOFFSIDES
669CataractOFFSIDES
670Catheter placementOFFSIDES
671Catheter related infectionOFFSIDES
672CellulitisOFFSIDES
673Central line infectionOFFSIDES
674Cerebral atrophy congenitalOFFSIDES
675Ceruloplasmin increasedOFFSIDES
676Chemical and Drug Induced Liver Injury

View details

CTD
677Chemotherapeutic drug level increasedOFFSIDES
678Choanal AtresiaCanada Vigilance: 1Canada Vigilance
679CholangiolitisOFFSIDES
680CholecystitisOFFSIDES
681Chronic Obstructive Airway DiseaseOFFSIDES
682Chronic sinusitisOFFSIDES
683CirrhosisOFFSIDES
684Citrobacter infectionOFFSIDES
685Clostridium difficile colitisOFFSIDES
686Cold sweatCanada Vigilance: 1Canada Vigilance
687ColitisOFFSIDES
688Colorectal cancer recurrentOFFSIDES
689ConfabulationOFFSIDES
690Congenital anomaly of adrenal glandCanada Vigilance: 1Canada Vigilance
691Congenital cerebral cystOFFSIDES
692Congenital cystic kidney diseaseCanada Vigilance: 1Canada Vigilance
OFFSIDES
693Congenital hearing disorderCanada Vigilance: 1Canada Vigilance
694Congenital heart diseaseOFFSIDES
695Congenital hepatobiliary anomalyCanada Vigilance: 1Canada Vigilance
696Congenital hydronephrosisCanada Vigilance: 1Canada Vigilance
697Congenital intestinal malformationCanada Vigilance: 2Canada Vigilance
OFFSIDES
698Congenital pyelocaliectasisOFFSIDES
699Congenital tricuspid valve incompetenceOFFSIDES
700Congenital urinary tract obstructionCanada Vigilance: 3Canada Vigilance
701Craniofacial Abnormalities8838193CTD
702Cross resistanceSIDER
703CryotherapyOFFSIDES
704Culture negativeSIDER
705Culture wound positiveOFFSIDES
706Cytomegalovirus chorioretinitisOFFSIDES
707Cytomegalovirus test positiveOFFSIDES
708Dark circles under eyesCanada Vigilance: 1Canada Vigilance
709Decreased LibidoOFFSIDES
710DemyelinationOFFSIDES
711Dental abscessOFFSIDES
712Depressed moodOFFSIDES
713Dermatomycoses18608918CTD
714DiabetesOFFSIDES
715Diabetes mellitus inadequate controlOFFSIDES
716Diabetic RetinopathyOFFSIDES
717Diabetic ulcerOFFSIDES
718DiarrheaOFFSIDES
719Diet refusalCanada Vigilance: 1Canada Vigilance
720Differential white blood cell count abnormalOFFSIDES
721DiverticulumOFFSIDES
722Ear and labyrinth disordersSIDER
723Endocarditis16283214CTD
724Endodontic procedureOFFSIDES
725EndophthalmitisOFFSIDES
726Enterobacter pneumoniaOFFSIDES
727Enterococcal infectionOFFSIDES
728Enterocolitis viralOFFSIDES
729EnterocolitisOFFSIDES
730Eosinophilic myocarditisOFFSIDES
731Erosive gastritisOFFSIDES
732Erythema InfectiosumOFFSIDES
733Escherichia infectionOFFSIDES
734Esophageal StenosisOFFSIDES
735Eustachian tube disorderOFFSIDES
736Exanthema10466905CTD
737Facial asymmetryCanada Vigilance: 1Canada Vigilance
738Facial wastingOFFSIDES
739Failure to ThriveOFFSIDES
740Fanconi SyndromeOFFSIDES
741Female sexual dysfunctionSIDER
742Femoral artery occlusionOFFSIDES
743Fluid overloadOFFSIDES
744Foreign body in respiratory tractCanada Vigilance: 1Canada Vigilance
745Fungemia24366741CTD
746Fungus serology test positiveOFFSIDES
747GamblingOFFSIDES
748GangreneOFFSIDES
749Gastric ulcerOFFSIDES
750Genital erosionOFFSIDES
751Glioblastoma18398572CTD
752GlobulinuriaOFFSIDES
753Glycosuria8442906CTD
754GoiterOFFSIDES
755GranulocytosisOFFSIDES
756Granulomatous liver diseaseOFFSIDES
757Guillain-Barre SyndromeCanada Vigilance: 2Canada Vigilance
758HaematotoxicityOFFSIDES
759Hallucinations, mixedOFFSIDES
760Hematoma, Epidural, Spinal12131644CTD
761HemiparesisOFFSIDES
762Heparin-induced thrombocytopeniaOFFSIDES
763Hepatic necrosisSIDER
764Hepatitis B positiveOFFSIDES
765Hepatitis COFFSIDES
766Hip surgeryOFFSIDES
767HistoplasmosisOFFSIDES
768Hyperbilirubinemia16940972CTD
769Hypercalcemia9767873CTD
770HyperkeratosisOFFSIDES
771HyperkinesiaSIDER
772HyperparathyroidismOFFSIDES
773Hyperviscosity syndromeOFFSIDES
774HypokinesiaCanada Vigilance: 1Canada Vigilance
SIDER
775Immune reconstitution syndromeOFFSIDES
776ImpetigoOFFSIDES
777Incision site complicationOFFSIDES
778IncontinenceOFFSIDES
779Infected cystOFFSIDES
780Infectious MononucleosisOFFSIDES
781InfestationSIDER
782Injected limb mobility decreasedCanada Vigilance: 1Canada Vigilance
783Injection site erythemaCanada Vigilance: 4Canada Vigilance
784Injection site massCanada Vigilance: 1Canada Vigilance
785Injection site painCanada Vigilance: 1Canada Vigilance
786Joint InstabilityOFFSIDES
787Joint injuryOFFSIDES
788Joint sprainOFFSIDES
789Kidney Diseases17580253CTD
790Kidney FailureOFFSIDES
791LacerationOFFSIDES
792LacrimationSIDER
793LaryngomalaciaCanada Vigilance: 3Canada Vigilance
794LaryngospasmCanada Vigilance: 1Canada Vigilance
795Left atrial dilatationOFFSIDES
796LeukoencephalopathyOFFSIDES
797Leukopenia neonatalOFFSIDES
798LeukorrheaSIDER
799Limb injuryOFFSIDES
800Lip erosionOFFSIDES
801Listeria sepsisOFFSIDES
802Live BirthOFFSIDES
803Liver Failure10631423CTD
804Liver Neoplasms, Experimental25656644CTD
805Liver diseases14966256
17580253
CTD
806Liver neoplasms25058030CTD
807Lung cystOFFSIDES
808Lung diseases14966256CTD
809Lupus NephritisOFFSIDES
810Lymphocyte count decreasedOFFSIDES
811MalnutritionSIDER
812Markedly reduced dietary intakeOFFSIDES
813Mastication disorderOFFSIDES
814Meningitis, Cryptococcal16983622CTD
815Meniscus removalOFFSIDES
816Metabolic acidosisOFFSIDES
817Metastases to thoraxOFFSIDES
818Metastatic NeoplasmOFFSIDES
819MetatarsalgiaOFFSIDES
820MetrorrhagiaSIDER
821MicrocephalyCanada Vigilance: 2Canada Vigilance
822Mouth BreathingOFFSIDES
823Multiple MyelomaOFFSIDES
824Multiple drug overdoseOFFSIDES
825Muscle strainOFFSIDES
826Musculoskeletal PainCanada Vigilance: 1Canada Vigilance
827Musculoskeletal discomfortSIDER
828Mycoses

View details

CTD
829Nephrogenic Fibrosing DermopathyOFFSIDES
830NoduleOFFSIDES
831Non-cardiac chest painOFFSIDES
832Onychomycosis14966256CTD
833Open reduction of fractureOFFSIDES
834OpisthotonusOFFSIDES
835Opportunistic mycosisSIDER
836Oropharyngitis fungalOFFSIDES
837OsteomalaciaCanada Vigilance: 1Canada Vigilance
838Osteomyelitis drainageOFFSIDES
839OsteomyelitisOFFSIDES
840OsteopeniaOFFSIDES
841Otomycosis21895787CTD
842PCO2 decreasedOFFSIDES
843Pancreatic InsufficiencyOFFSIDES
844Pericardial effusionOFFSIDES
845Peritonitis7566587CTD
846Pharyngeal candidiasisOFFSIDES
847PharyngitisCanada Vigilance: 2Canada Vigilance
SIDER
848PhonophobiaCanada Vigilance: 2Canada Vigilance
849PlagiocephalyCanada Vigilance: 6Canada Vigilance
850PolydactylyOFFSIDES
851Polymyalgia RheumaticaCanada Vigilance: 1Canada Vigilance
852PolyuriaOFFSIDES
SIDER
853Poor feeding infantCanada Vigilance: 1Canada Vigilance
854Portal HypertensionOFFSIDES
855Post procedural complicationOFFSIDES
856Prenatal Exposure Delayed Effects28637461CTD
857Protein total decreasedOFFSIDES
858Protein total increasedOFFSIDES
859Proteinuria8442906CTD
860Prothrombin level decreasedOFFSIDES
861Psychiatric symptomOFFSIDES
862Pulmonary HypertensionOFFSIDES
863Pulmonary artery stenosisCanada Vigilance: 2Canada Vigilance
864Pulmonary congestionOFFSIDES
865Pulmonary toxicityOFFSIDES
866Purulent dischargeOFFSIDES
867Pyloric StenosisCanada Vigilance: 1Canada Vigilance
868Radiotherapy to brainOFFSIDES
869Relapsing FeverOFFSIDES
870Renal cystOFFSIDES
871Renal painSIDER
872Respiratory DepressionCanada Vigilance: 1Canada Vigilance
873Seizures11034273CTD
874SequestrectomyOFFSIDES
875Serotonin Syndrome18585543CTD
876Shallow breathingSIDER
877Skin IndurationOFFSIDES
878Splenic InfarctionOFFSIDES
879Sputum culture positiveOFFSIDES
880Stem cell transplantOFFSIDES
881Stupor10466905CTD
882Subcutaneous AbscessOFFSIDES
883Subcutaneous noduleOFFSIDES
884Swelling of eyelidCanada Vigilance: 4Canada Vigilance
885SynovitisOFFSIDES
886Systemic candidiasis19141735CTD
887TalipesCanada Vigilance: 1Canada Vigilance
888Tarsal Tunnel SyndromeOFFSIDES
889TensionSIDER
890ThrombophlebitisOFFSIDES
891Tinea Pedis9762826CTD
892Tinea Versicolor12060505CTD
893Tooth ExtractionOFFSIDES
894Torsades de Pointes

View details

CTD
895ToxoplasmosisOFFSIDES
896TracheitisOFFSIDES
897UlcerOFFSIDES
898Urinary IncontinenceSIDER
899Urine flow decreasedCanada Vigilance: 1Canada Vigilance
900Urine output increasedCanada Vigilance: 1Canada Vigilance
SIDER
901Uterine spasmSIDER
902Vaccination site rashCanada Vigilance: 1Canada Vigilance
903Vascular anomalyOFFSIDES
904Venous InsufficiencyOFFSIDES
905Vocal cord cystOFFSIDES
906Vulvovaginal drynessOFFSIDES
907carbuncleOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.